Treatment of metastatic colorectal cancer using anti-VEGFR-2 and anti-VEGF-D antibodies
- 专利权人:
- イーライ リリー アンド カンパニー
- 发明人:
- レベッカ・ローズ・ホザック,タラ・スザンヌ・アンバーガー
- 申请号:
- JP2019543198
- 公开号:
- JP2019533024A
- 申请日:
- 2017.11.10
- 申请国别(地区):
- JP
- 年份:
- 2019
- 代理人:
- 摘要:
- The present invention provides methods, treatments and uses related to anti-human VEGFR-2 antibodies for the treatment of metastatic colorectal cancer in patients with high levels of VEGF-D.本発明は、高レベルのVEGF-Dを有する患者における転移性結腸直腸癌の治療のための、抗ヒトVEGFR-2抗体に関する方法、治療、および使用を提供する。
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- TUMOR THERAPY WITH AN ANTIBODY FOR VASCULAR ENDOTHELIAL GROWTH FACTOR AND AN ANTIBODY FOR HUMAN EPITHELIAL GROWTH FACTOR RECEPTOR TYPE 2
- Tumor Therapy with an Antibody for Vascular Endothelial Growth Factor and an Antibody for Human Epithelial Growth Factor Receptor Type 2
- Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2
- TUMOR THERAPY WITH AN ANTIBODY FOR VASCULAR ENDOTHELIAL GROWTH FACTOR AND AN ANTIBODY FOR HUMAN EPITHELIAL GROWTH FACTOR RECEPTOR TYPE 2
- ANTIBODY TO VASCULAR ENDOTHELIAL GROWTH FACTOR, AND TUMOR TREATMENT USING ANTIBODY FOR HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR TYPE 2